The Use of Not-Negative Conclusions to Describe Results of Formally Negative Trials Presented at Oncology Meetings

JAMA Oncol. 2020 Jun 1;6(6):926-927. doi: 10.1001/jamaoncol.2020.0475.

Abstract

This quality improvement analysis of oral presentations of phase 3 randomized clinical trials evaluates the frequency and risks of emphasizing results of borderline significance.

MeSH terms

  • Clinical Trials, Phase III as Topic / classification*
  • Communication*
  • Congresses as Topic*
  • Medical Oncology
  • Randomized Controlled Trials as Topic / classification*
  • Societies, Medical